Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
BioAnalab offers a contract testing service to the biopharmaceutical industry for the rapidly growing area of therapeutic monoclonal antibodies, with a longer-term strategy to develop diagnostics to measure levels of monoclonal antibodies and their immune response. In July 2009, BioAnaLab was acquired by Millipore Corp.
Incorporated in November 2002
Origin: Oxford University, Department of Pathology
Expertise and knowledge regarding data privacy, ethics, data security and public policy in connection with technology use.
Incorporated in August 2020
Origin: Oxford University, The Oxford Internet Institute
Using phase change materials for smart glazing and displays.
Incorporated in November 2015
Origin: Oxford University, Department of Materials
Development of asthma monitoring system
Incorporated in November 2017
Origin: Oxford University, Department of Engineering Science
Electrical and software controls for lithium ion battery storage.
Incorporated in November 2017
Origin: Oxford University, Department of Engineering Science
A proprietary multi-omics discovery platform to resolve RNA-centric mechanisms in rare and chronic diseases.
Incorporated in December 2022
Origin: Oxford University, NDORMS
Software development for a novel biomarker to detect coronary heart disease.
Incorporated in July 2018
Origin: Oxford University, Radcliffe Department of Medicine
Advanced materials and technologies in safe, lightweight, high performance hydrogen storage technology.
Incorporated in January 2011
Origin: Oxford University, Science and Technology Facilities Council
Celleron is an oncology healthcare company that has developed biomarkers using epigenetic techniques that match drugs to responsive disease.
Incorporated in November 2005
Origin: Oxford University, Sir William Dunn School of Pharmacology
Software/hardware solutions
Incorporated in November 1998
Origin: Oxford University, Department of Computer Science
Circadian Therapeutics identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.
Incorporated in September 2016
Origin: Oxford University, Ophthalmology
ClinOx offers clients knowledge and expertise in the development, placement, conduct and analysis of early phase oncology clinical trials, with particular emphasis on pharmacokinetic and mechanistic endpoints.
Incorporated in June 2007
Origin: Oxford University, Nuffield Division of Clinical and Laboratory Sciences
Using leading edge human biomimetic platforms to test and develop therapeutics for serious human diseases.
Incorporated in July 2009
Origin: Oxford University, Institute of Biomedical Engineering
Cocotec builds software tools, which harness the power of automated formal verification. Its product, the Coco Platform, comes with a powerful software development environment that enables developers to build their software, automatically verify whether it is correct, and then generate high quality reliable code.
Incorporated in November 2018
Origin: Oxford University, Department of Computer Science
Focus on the synthesis of natural products.
Incorporated in December 2018
Origin: Oxford University, Department of Chemistry
A broadcast personalisation engine to revolutionise audience experience.
Incorporated in January 2017
Origin: Oxford University, Department of Computer Science
Digital CBTe software.
Incorporated in December 2022
Origin: Oxford University, Department of Psychiatry
Crysalin develop a protein lattice technology that is founded on a novel form of highly ordered materials, crysalins, that are produced through modification of naturally occurring protein building blocks.
Incorporated in June 2007
Origin: Oxford University, Department of Biochemistry
Cutting edge laser technology company.
Incorporated in February 2021
Origin: Oxford University, Department of Engineering Science
Cytox develops a technology platform for tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias.
Incorporated in October 2006
Origin: Oxford University, Nuffield Department of Clinical Neurosciences
